Skip to Content

Riquent Approval Status

  • FDA approved: No
  • Brand name: Riquent
  • Generic name: abetimus sodium
  • Company: La Jolla Pharmaceutical Company
  • Treatment for: Systemic Lupus Erythematosus

Development Status and FDA Approval Process for Riquent

DateArticle
Mar 14, 2005La Jolla Pharmaceutical Announces Outcome of Recent FDA Discussions
Oct 14, 2004La Jolla Pharmaceutical Company Receives Letter From FDA About Riquent
Feb 17, 2004La Jolla Pharmaceutical’s New Drug Application for Lupus Drug Candidate Riquent Accepted for Review by FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide